These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14652787)

  • 21. Janus faces of microglia in multiple sclerosis.
    Sanders P; De Keyser J
    Brain Res Rev; 2007 Jun; 54(2):274-85. PubMed ID: 17383006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory biomarkers in acute coronary syndromes: part IV: matrix metalloproteinases and biomarkers of platelet activation.
    Armstrong EJ; Morrow DA; Sabatine MS
    Circulation; 2006 Mar; 113(9):e382-5. PubMed ID: 16520416
    [No Abstract]   [Full Text] [Related]  

  • 23. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acinetobacter immune responses in multiple sclerosis: etiopathogenetic role and its possible use as a diagnostic marker.
    Ebringer A; Hughes L; Rashid T; Wilson C
    Arch Neurol; 2005 Jan; 62(1):33-6. PubMed ID: 15642847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exhaled breath condensate as a method of sampling airway nitric oxide and other markers of inflammation.
    Liu J; Thomas PS
    Med Sci Monit; 2005 Aug; 11(8):MT53-62. PubMed ID: 16049390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis.
    Fainardi E; Castellazzi M; Tamborino C; Trentini A; Manfrinato MC; Baldi E; Tola MR; Dallocchio F; Granieri E; Bellini T
    Mult Scler; 2009 May; 15(5):547-54. PubMed ID: 19318509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A branched-chain organic acid linked to multiple sclerosis: first identification by NMR spectroscopy of CSF.
    Lutz NW; Viola A; Malikova I; Confort-Gouny S; Ranjeva JP; Pelletier J; Cozzone PJ
    Biochem Biophys Res Commun; 2007 Mar; 354(1):160-4. PubMed ID: 17217913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological patterns identifying disease course and evolution in multiple sclerosis patients.
    Furlan R; Rovaris M; Martinelli Boneschi F; Khademi M; Bergami A; Gironi M; Deleidi M; Agosta F; Franciotta D; Scarpini E; Uccelli A; Zaffaroni M; Kurne A; Comi G; Olsson T; Filippi M; Martino G
    J Neuroimmunol; 2005 Aug; 165(1-2):192-200. PubMed ID: 15949850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.
    Freund-Levi Y; Hjorth E; Lindberg C; Cederholm T; Faxen-Irving G; Vedin I; Palmblad J; Wahlund LO; Schultzberg M; Basun H; Eriksdotter Jönhagen M
    Dement Geriatr Cogn Disord; 2009; 27(5):481-90. PubMed ID: 19439966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokine network in multiple sclerosis: role in pathogenesis and targeting for future treatments.
    Galimberti D; Bresolin N; Scarpini E
    Expert Rev Neurother; 2004 May; 4(3):439-53. PubMed ID: 15853541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute neuroinflammation in Lewis rats - a model for acute multiple sclerosis relapses.
    Schneider C; Schuetz G; Zollner TM
    J Neuroimmunol; 2009 Aug; 213(1-2):84-90. PubMed ID: 19560215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological markers in body fluids for activity and progression in multiple sclerosis.
    Sørensen PS
    Mult Scler; 1999 Aug; 5(4):287-90. PubMed ID: 10467390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing-remitting multiple sclerosis.
    Greco A; Minghetti L; Puopolo M; Cannoni S; Romano S; Pozzilli C; Levi G
    J Neurol Sci; 2004 Sep; 224(1-2):23-7. PubMed ID: 15450767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory markers in relation to insulin resistance and the metabolic syndrome.
    Ingelsson E; Hulthe J; Lind L
    Eur J Clin Invest; 2008 Jul; 38(7):502-9. PubMed ID: 18489581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological markers in multiple sclerosis.
    Gironi M; Bergami A; Brambilla E; Ruffini F; Furlan R; Comi G; Martino G
    Neurol Sci; 2000; 21(4 Suppl 2):S871-5. PubMed ID: 11205366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth-associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis.
    Teunissen CE; Dijkstra CD; Jasperse B; Barkhof F; Vanderstichele H; Vanmechelen E; Polman CH; Bö L
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):318-31. PubMed ID: 16640650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sclerosis and Alzheimer's disease.
    Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
    Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetranectin in cerebrospinal fluid of patients with multiple sclerosis.
    Stoevring B; Jaliashvili I; Thougaard AV; Ensinger C; Høgdall CK; Rasmussen LS; Sellebjerg F; Christiansen M
    Scand J Clin Lab Invest; 2006; 66(7):577-83. PubMed ID: 17101549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA-based vaccines: the future of multiple sclerosis therapy?
    Stüve O; Cravens PD; Eagar TN
    Expert Rev Neurother; 2008 Mar; 8(3):351-60. PubMed ID: 18345967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
    Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.